Paper ยท 33859400
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires.
Keating SM and 47 others. Nat Biotechnol, 2021. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Generation of recombinant hyperimmune globulins from diverse B-cell repertoires. Papers, record 33859400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859400
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| COVID-19 | Major topic |
| Globulins | Major topic |
| SARS-CoV-2 | Major topic |
| Animals | |
| Antibodies, Viral | |
| CHO Cells | |
| Cricetulus | |
| Enzyme-Linked Immunosorbent Assay | |
| Humans | |
| Immunization, Passive | |
| Mice | |
| Recombinant Proteins | |
| Zika Virus | |
| COVID-19 Serotherapy |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R44 AI115892 | NIAID NIH HHS | United States | R44AI115892 | PubMed and NIH | NIH RePORTER |
| R44 AI124901 | NIAID NIH HHS | United States | R44AI124901 | PubMed and NIH | NIH RePORTER |
| R44AI124901 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | R44AI124901 | PubMed and NIH | NIH RePORTER | |
| 1230150 | National Science Foundation (NSF) | PubMed | PubMed | ||
| R44AI115892 | U.S. Department of Health & Human Services | National Institutes of Health (NIH) | R44AI115892 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04883138 | Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,480,779 | Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role. | Expert Rev Anti Infect Ther | 2017 | https://conductscience.org/library/papers/28480779 | PubMed |
| 2 | 6,339,349 | Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. | Hepatology | 1983 | https://conductscience.org/library/papers/6339349 | PubMed |
| 3 | 29,229,452 | Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure. | J Pediatr | 2018 | https://conductscience.org/library/papers/29229452 | PubMed |
| 4 | 9,679,818 | Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. | Transplantation | 1998 | https://conductscience.org/library/papers/9679818 | PubMed |
| 5 | 31,285,451 | Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice. | Sci Rep | 2019 | https://conductscience.org/library/papers/31285451 | PubMed |
| 6 | 32,254,064 | Deployment of convalescent plasma for the prevention and treatment of COVID-19. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32254064 | PubMed |
| 7 | 32,219,428 | Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. | JAMA | 2020 | https://conductscience.org/library/papers/32219428 | PubMed |
| 8 | 12,556,024 | Responding to the immunoglobulin shortage: a case study. | J Health Polit Policy Law | 2002 | https://conductscience.org/library/papers/12556024 | PubMed |
| 9 | 7,526,215 | Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. | N Engl J Med | 1994 | https://conductscience.org/library/papers/7526215 | PubMed |
| 10 | 21,545,600 | Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products. | Vox Sang | 2012 | https://conductscience.org/library/papers/21545600 | PubMed |
1 to 10 of 46
See all 46 referencesCited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,909,796 | Base editing-mediated exon-specific knockout of glutamine synthetase generates a high-productivity CHO cell line for antibody manufacturing. | Bioresour Bioprocess | 2026 | https://conductscience.org/library/papers/42909796 | PubMed |
| 42,003,948 | Sterility, safety, and preventive efficacy of three polyvalent hyperimmune sera against bacterial infection in a white mouse challenge model. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42003948 | PubMed |
| 39,689,695 | High-throughput specificity profiling of antibody libraries using ribosome display and microfluidics. | Cell Rep Methods | 2024 | https://conductscience.org/library/papers/39689695 | PubMed |
| 39,380,504 | Single-Batch Expression of an Experimental Recombinant Snakebite Antivenom Based on an Oligoclonal Mixture of Human Monoclonal Antibodies. | Biotechnol J | 2024 | https://conductscience.org/library/papers/39380504 | PubMed |
| 39,366,976 | Developing a workflow for the isolation of hybridoma cells producing fully human antigen-specific antibodies using a surface IgG detection method. | Sci Rep | 2024 | https://conductscience.org/library/papers/39366976 | PubMed |
| 39,240,970 | Fluorescence-activated droplet sequencing (FAD-seq) directly provides sequences of screening hits in antibody discovery. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39240970 | PubMed |
| 39,055,704 | Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023). | Front Immunol | 2024 | https://conductscience.org/library/papers/39055704 | PubMed |
| 38,877,201 | Hyperimmune Globulins in COVID-19. | Curr Top Microbiol Immunol | 2025 | https://conductscience.org/library/papers/38877201 | PubMed |
| 37,324,547 | Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5. | Antib Ther | 2023 | https://conductscience.org/library/papers/37324547 | PubMed |
| 37,243,248 | False-Positive Screening and Confirmatory HIV Diagnostic Test in a Patient with Cured SARS-CoV-2 Infection Is Not Mediated by Env/Spike Cross-Reactive Antibodies. | Viruses | 2023 | https://conductscience.org/library/papers/37243248 | PubMed |
1 to 10 of 18
See all 18 cited byGenes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59,272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| IGK | 50,802 | PubTator's text mining | https://conductscience.org/library/genes/50802 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PTPRC | 5,788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
| RHO | 6,010 | PubTator's text mining | https://conductscience.org/library/genes/6010 | NCBI Gene |
| TRBV20OR9-2 | 6,962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33859400
GET https://conductscience.org/api/papers/v1/33859400/authors?page=2